Acetazolamide Capsule
Product Images NDC 65841-762

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 65841-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (5fb4882a 0d87 4775 A7cf 43b05296f616 01)

Figure (5fb4882a 0d87 4775 A7cf 43b05296f616 01)
Chemical structure of acetazolamide shown as a ring with sulfur (S), nitrogen (N), and carbon atoms, including attached groups such as H2NO2S and NHCOCH3, representing the molecular structure of the active ingredient acetazolamide.*
FDA Label Image

Figure (5fb4882a 0d87 4775 A7cf 43b05296f616 02)

Figure (5fb4882a 0d87 4775 A7cf 43b05296f616 02)
Label of acetazolamide extended-release capsules, 500 mg, by Zydus Lifesciences Limited. The label shows a single capsule illustrated with the imprint 'XYL 34'. The package contains 100 capsules. Storage instructions and a note to keep out of reach of children are included. Manufactured by Cadila Healthcare Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.